Alain Patrick Algazi

14PUBLICATIONS
85CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsPredictive and prognostic markersNanotoxicology, health and safety
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (14)

|Jan 03, 2025
Comparative Analysis of Intracranial Response Assessment Criteria in Patients With Melanoma Brain Metastases Treated With Combination Nivolumab + Ipilimumab in CheckMate 204.

Raymond Y Huang, Gilbert Youssef, Thomas Nelson

|Apr 17, 2024
Phase II, Single-Arm Trial of Induction and Concurrent Vismodegib With Curative-Intent Radiation Therapy for Locally Advanced, Unresectable Basal Cell Carcinoma.

Christopher A Barker, Suzanne Dufault, Sarah T Arron

|Jan 23, 2024
A phase 1 study of triple-targeted therapy with BRAF, MEK, and AKT inhibitors for patients with BRAF-mutated cancers.

Alain P Algazi, James Moon, Christopher D Lao

|May 22, 2023
A prospective evaluation of neck and shoulder function following treatments of early-stage human papillomavirus-associated oropharynx cancer.

Arushi Gulati, Karolina Plonowska-Hirschfeld, Erika M Stephens

|Dec 01, 2022
Safety and Efficacy of MEDI0457 plus Durvalumab in Patients with Human Papillomavirus-Associated Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma.

Charu Aggarwal, Nabil F Saba, Alain Algazi

|Aug 02, 2022
Tilsotolimod Exploits the TLR9 Pathway to Promote Antigen Presentation and Type 1 IFN Signaling in Solid Tumors: A Multicenter International Phase I/II Trial (ILLUMINATE-101).

Hani Babiker, Erkut Borazanci, Vivek Subbiah

Pageof 3

Frequent Collaborators

3 joint publications

Antoni Ribas

2 joint publications

Paolo A Ascierto

2 joint publications

Marcus O Butler

2 joint publications

Jose Lutzky